Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.
Brooklands Hospital, Coventry and Warwickshire Partnership NHS Trust, Birmingham, UK.
Health Technol Assess. 2024 Oct;28(72):1-147. doi: 10.3310/MWTQ5721.
Interventions for anxiety need to be adapted to meet the needs of autistic people with moderate to severe learning disabilities and successfully modelled before evidence about efficacy can be generated from clinical trials.
The objectives were to: (1) adapt a behavioural intervention for anxiety, develop an intervention fidelity checklist and logic model, and appraise candidate outcome measures, together with carers, autistic people, and clinicians, (2) characterise treatment-as-usual, (3) model the adapted intervention to determine the acceptability and feasibility for all stakeholders, judge the appropriateness of outcome measures, examine the feasibility and acceptability of consent and associated processes and (4) describe factors that facilitate or challenge intervention delivery.
This study had two phases. Phase 1a: using consensus methods, an intervention adaptation group was formed who met to adapt the intervention, appraise candidate outcome measures, and contribute to the development of the intervention fidelity checklists and logic model. Phase 1b: a national online survey was conducted with professionals to characterise treatment-as-usual. Phase 2: this was a single-group non-randomised feasibility study designed to model the intervention to test intervention feasibility and acceptability, outcome measures, and aspects of the research process.
Participants were recruited from National Health Service community adult learning disabilities teams in England.
Participants aged 16 and over with a diagnosis of autism, moderate to severe learning disabilities, an anxiety disorder, and a carer who was available to take part in the intervention. For those who lacked capacity to make a decision about taking part, a consultee had to provide advice that the participant should be included in the study.
The intervention comprised 12 sessions alongside treatment-as-usual.
The feasibility and acceptability of the intervention and research processes, outcome measure completion rates, and intervention adherence.
The intervention was successfully adapted and modelled with 28 autistic participants with moderate to severe learning disabilities. The intervention was judged to be feasible and acceptable by autistic adults with learning disabilities, carers, and therapists. Carers and therapists suggested minor intervention revisions. Carers completed 100% of outcome measures and the missing data rate was low; however, they indicated that some of the questions were repetitive and said they had difficulty responding to some items. The use of the Mental Capacity Act, 2005, led to an average 5-week delay to participant enrolment. The accrual rate was affected by the COVID-19 pandemic and improved during the summer and early autumn of 2022.
Randomisation was not modelled within this feasibility study, although carers and therapists indicated that this would be acceptable.
The BEAMS-ID intervention and associated study processes were judged to be feasible and acceptable. The intervention required minor revision.
The BEAMS-ID intervention should be tested further within a trial.
This study is registered as ISRCTN12637590.
This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR129804) and is published in full in ; Vol. 28, No. 72. See the NIHR Funding and Awards website for further award information.
干预措施需要适应自闭症患者的需求,这些患者有中度至重度学习障碍,并且需要在临床试验产生疗效证据之前成功建模。
目标是:(1)改编焦虑的行为干预措施,制定干预可信度检查表和逻辑模型,并与护理人员、自闭症患者和临床医生一起评估候选结果测量指标,(2)描述常规治疗情况,(3)对改编后的干预措施进行建模,以确定所有利益相关者的可接受性和可行性,判断结果测量指标的适当性,检查同意书和相关流程的可行性和可接受性,(4)描述促进或挑战干预措施实施的因素。
本研究分为两个阶段。第 1a 阶段:使用共识方法,成立了一个干预适应小组,该小组开会改编干预措施,评估候选结果测量指标,并为干预可信度检查表和逻辑模型的制定做出贡献。第 1b 阶段:对全国的专业人员进行了一项在线调查,以描述常规治疗情况。第 2 阶段:这是一项非随机可行性单组研究,旨在对干预措施进行建模,以测试干预措施的可行性和可接受性、结果测量指标以及研究过程的各个方面。
参与者是从英格兰国家卫生服务社区成人学习障碍团队中招募的。
年龄在 16 岁及以上,有自闭症、中度至重度学习障碍、焦虑症的诊断,并且有护理人员可参与干预措施。对于那些没有能力决定是否参与的人,必须由顾问提供建议,让参与者参与研究。
干预措施包括与常规治疗一起进行的 12 次治疗。
干预措施和研究过程的可行性和可接受性、结果测量指标的完成率和干预措施的依从性。
成功改编和建模了针对 28 名有中度至重度学习障碍的自闭症患者的干预措施。患有学习障碍的自闭症成年人、护理人员和治疗师认为该干预措施是可行和可接受的。护理人员和治疗师提出了一些轻微的干预修改建议。护理人员完成了 100%的结果测量指标,缺失数据率较低;然而,他们表示一些问题是重复的,并且表示他们难以回答一些项目。使用 2005 年《精神能力法》导致参与者的入组平均延迟了 5 周。入组率受到 COVID-19 大流行的影响,并在 2022 年夏季和初秋有所改善。
虽然护理人员和治疗师表示可以接受,但在这项可行性研究中没有对随机化进行建模。
BEAMS-ID 干预措施和相关研究过程被认为是可行和可接受的。该干预措施需要进行一些小的修改。
BEAMS-ID 干预措施应在试验中进一步进行测试。
本研究在 ISRCTN 注册,注册号为 ISRCTN129804。
该奖项由英国国家卫生与保健卓越研究所(NIHR)健康技术评估计划(NIHR 奖 REF:NIHR129804)资助,并在 ;第 28 卷,第 72 期。有关该奖项的更多信息,请访问 NIHR 资助和奖项网站。